Background: The ability of intraoperative frozen section (IFS) to reliably diagnose renal tumors in children and adolescents is largely unknown. The objective of our study is to evaluate the ability of IFS to establish a histologic diagnosis for renal tumors in this population. 
INTRODUCTION
Renal tumors are the fourth most common tumor in children accounting for 5-7% of newly diagnosed childhood cancers. 1 the pediatric literature. The use of IFS has the potential to guide the need for adjunctive surgical procedures and provide clinical information to the patient's family in a timely manner. However, the true utility of IFS in the care of children and adolescents with suspicious renal tumors is largely unknown. The primary objective of our study is to evaluate the reliability of IFS for renal tumors in children and adolescents. We hypothesize that IFS is reliable to establish a histologic diagnosis in the management of children and adolescents with renal tumors.
METHODS

Study design
The electronic medical records of patients who underwent radical nephrectomy, partial nephrectomy, or incisional biopsy for a suspicious 
Study criteria
Patients were excluded if they underwent nephrectomy, partial nephrectomy, or biopsy for an indication other than a renal tumor suspicious for malignancy. Only IFS and FP from the primary tumor were evaluated. The IFS on lymph nodes, metastatic lesions, fine needle biopsy/aspiration, or surgical margins were excluded from this analysis.
Data analysis
Cohen's kappa coefficient was utilized to assess the concordance rate between IFS and FP with regard to histologic subtypes, benign versus malignant pathology, and Wilms versus non-Wilms tumor classification. Sensitivity, specificity, negative predictive value (NPV) and positive predictive value (PPV) to differentiate malignant from benign tumors, and Wilms tumors from non-Wilms tumors were calculated with 95% confidence intervals (CIs) for each parameter.
The data analysis was generated using SAS software, version 9.3 (Cary, NC).
RESULTS
During the study period, 130 patients met study criteria and underwent surgical interventions for a renal tumor at a median age of 37 months (range . Of these, 12 (9.2%) patients had surgery for 
DISCUSSION
IFS was first brought into practice in 1905, and it now plays an important role in the management of many surgical patients. [6] [7] [8] In general, the use of IFS has a reported diagnostic accuracy between 78% and 98% in pediatric solid tumors. 7,9-12 However, this diagnostic tool is utilized in less than 8% of pediatric surgical specimens, with renal tumors accounting for less than 3% of these. 7, 10 In our 10-year review of patients with renal tumors, IFS was utilized in 25% of the cases of unilateral nephrectomy, partial nephrectomy, and incisional biopsy. deferred cases. In this report, there were 11 renal tumor specimens.
The IFS accurately differentiated between Wilms (n = 7) and nonWilms (n = 4) in 91% of cases, and correctly diagnosed Wilms tumors in 86% of cases. In our study, we found that IFS histology correlated correctly in 81% of cases (90% when adjusting for deferred cases). Similarly, IFS was able to correctly distinguish between Wilms tumor and non-Wilms in 94% of cases, and Wilms tumor was correctly diagnosed in 89.5% of cases. Thus, the use of IFS for diagnosis of Wilms tumor has a high sensitivity (89%) and specificity (100%). We observed a histologic discordant and deferred rate of 9.4% each. This is similar to the 7-9% discordant rate and 14% deferred rate previously observed in both adult and pediatric renal tumors. 7, 15 These rates in renal tumors are within the 2-21% discordant and 2.5-25% deferred rates observed in all pediatric solid tumor specimens submitted for IFS. 7, [9] [10] [11] [12] In keeping with prior publications on this topic, we believe these rates to be acceptable. 7, 10, 11 Logistically, the addition of IFS should have little negative impact to the ongoing procedure. The median turnaround time for IFS in is important, and providers should work toward minimizing these limitations as much as possible to maximize the diagnostic yield. Limitations of IFS include sampling errors, technical problems, and interpretative errors. 7 At our institution, IFS is interpreted by fellowshiptrained pediatric pathologists with experience of these rare tumors. As such, our results cannot be extrapolated to all centers. In addition, the IFS specimens were interpreted by more than two pathologists in 75% of cases, and FP was reviewed internally or externally in 91% of cases to confirm the diagnosis. To avoid sampling error, we only evaluated IFS performed on a segment from the whole specimen (97%) or incisional biopsy (3%), and we did not include needle biopsy specimens.
It is important to note that IFS is typically performed in a small portion of the specimen, and therefore it is not a reliable way to detect anaplasia (unfavorable histology) an important pathologic factor in the management of Wilms tumor. Current protocols for the examination of specimens from patients with Wilms tumors or other pediatric renal tumors supports the use of IFS from a bivalved nephrectomy specimen when the operative procedure will be altered by the results. 18 Thus, IFS should be used prudently in situations that will impact immediate intraoperative management, and indiscriminate usage, including performing IFS only for preliminary diagnostic information, should be avoided. 7, 10 
CONCLUSIONS
Based on our observations, IFS appears to offer a reliable and accurate tool to establish a histologic diagnosis, distinguish between malignant and benign tumors, and to differentiate Wilms from nonWilms tumors in children and adolescents with renal tumors. Communication between the surgeon and pathologist is of utmost importance when dealing with these rare renal tumors to ensure the proper and efficient use of IFS. Specifically, we advocate the use of IFS in cases in which obtaining a histologic diagnosis will provide guidance for "realtime" medical decision making and adjunctive surgical interventions.
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